NCT06480110 Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06439225 Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes Status RECRUITING Phase PHASE3
NCT06402331 FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06401980 Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status RECRUITING Phase PHASE2
NCT06383052 A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06380738 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) Status RECRUITING Phase N/A
NCT06329830 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT06318273 A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT06303713 LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06250244 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06229366 [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06228404 Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT06228053 Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT06221774 Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06193486 Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC Status RECRUITING Phase PHASE1
NCT06155084 A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients Status RECRUITING Phase PHASE1/PHASE2
NCT06136598 A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) Status COMPLETED Phase PHASE1
NCT06104449 A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) Status COMPLETED Phase PHASE1
NCT06100705 Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC Status RECRUITING Phase PHASE2